(718) 670-1501 
(718) 445-9846RESEARCH
CLINICAL
- Principle Clinical Investigator- Phase II - Study of Cisplatin and Radiation "Sandwich" Therapy in patients with Uterine Papillary Serous Carcinoma. Albert Einstein College of Medicine 2001-2002.
- Co-Investigator - an open level phase I, dose excalation study of tumor necrosis factor a(TNFerade) gene therapy with Radiation Therapy for locally advanced recurrent or metastic tumors. Albert Einstein College of Medicine 2001?2002.
- Principle Clinical Investigator- Small cell study, A Phase II Trial to Evaluate the Effect of Amifostine as a Radioprotector in Reducing Grade 2-4 Esophagitis and Pneumonitis in Small Cell Lung Cancer Patients Treated with Concomitant Chemotherapy and Twice a day Radiation Therapy.
- Principle Clinical Investigator- Quality of Life evaluation in patients receiving adjuvant Radiotherapy for breast cancer., 2003-present.
- Principle Clinical Investigator- Quality of Life evaluation in patients receiving radiotherapy and or brachytherapy for Prostate Carcinoma. 2003-present.
- Principle Clinical Investigator- Quality of Life evaluation in patients receiving Palliative Radiotherapy., 2003-present.
BASIC
- Molecular modulation with Iressa in Cervical carcinoma cell lines to enhance sensitivity to radiotherapy and chemotherapy.
- Molecular modulation with OSI-774 in Head and Neck carcinoma cell lines to enhance sensitivity to radiotherapy and chemotherapy
SPECIAL INTERESTS
- Low dose/high dose rate brachytherapy.
- GYN, Head & Neck, Prostate, and Soft Tissue Sarcoma Brachytherapy.
- Combined Modality and 3D Radiation Therapy.
- Intravascular and stereotactic Radiotherapy.
- Brachytherapy prototype designs.
- Cancer and complementary therapies.
Back to Top